German China

USA: Potential Coronavirus Solution

U.S. Initiates Testing of Potential Covid-19 Vaccine

| Editor: Ahlam Rais

The testing of the vaccines on people is essential to determine if it is safe and can fight the coronavirus.
Gallery: 1 image
The testing of the vaccines on people is essential to determine if it is safe and can fight the coronavirus. (Source: Deposit Photos)

Testing of the potential covid-19 vaccine – mrna-1273 developed by the National Institutes of Health and biotechnology firm Moderna has started in the USA. If the research proves successful, the company will be able to mass produce the cure only after 12 to 18 months.

USA – The U.S. has recently begun testing its potential covid-19 vaccine called mrna-1273 by vaccinating four healthy volunteers in the country. The vaccine has been developed by the National Institutes of Health (NIH) and biotechnology firm Moderna in record time and one of the major factors towards this success was the availability of the virus’ genetic sequence by Chinese scientists.

The testing of the vaccines on people is essential to determine if it is safe and can fight the virus. According to news reports, Dr. Anthony Fauci of the U.S. National Institutes of Health states, “Even if the research goes well, a vaccine would not be available for widespread use for 12 to 18 months.”

With the rise in the number of deaths and people affected by the virus around the world, there are many other companies hurrying to create a potential covid-19 vaccine including Curevac, Inovio Pharmaceuticals, Pfizer and many more.

Comments are being loaded ....

Leave a comment

The comment is checked by an editor and will be released soon.

  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Contact us via: support.vogel.de/ (ID: 46413180 / Laborpraxis Worldwide)